Zevra Therapeutics: Q1 Earnings Snapshot
Zevra Therapeutics, Inc. (ZVRA) on Thursday announced that its board has authorized a share repurchase program of up to $5 million of its common stock.
CELEBRATION, Fla.
Celebration, Florida based company reported a loss per share of 34 cents.
The specialty pharmaceutical company reported revenue of $2.9 millions in the period.
This story was created by
Automated Insights
(
URL
Zacks Investment Research data. Access to a
Zacks Stock Report on ZVRA
You can also check out our Facebook page.
URL